Format

Send to

Choose Destination
Med Care. 2005 Jul;43(7 Suppl):15-9.

Incorporating economic evaluations into decision-making: the Ontario experience.

Author information

1
Institute for Clinical Evaluative Sciences, Division of General Internal Medicine, Sunnybrook and Women's Health Sciences Centre, and the Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. alaupacis@ices.on.ca

Abstract

The Drug Quality and Therapeutics Committee (DQTC) and the Canadian Expert Drug Assessment Committee (CEDAC) make reimbursement recommendations to publicly funded outpatient drug plans in Ontario and Canada respectively. In this article, the organization and decision-making processes of these committees are described. Issues associated with these committees such as potential biases associated with pharmaceutical company submissions, transparency, restricted access programs, conditional listing, and price negotiation are discussed.

PMID:
16056004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center